Home
Browse
Search
Statistics
About
Usage
PMID: 12223492
Loo TW, Clarke DM
Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein.
J Biol Chem. 2002 Nov 15;277(46):44332-8. Epub 2002 Sep 9., 2002-11-15
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
130
ABCB1 p.Met68Cys
X
ABCB1 p.Met68Cys 12223492:130:16
status:
NEW
view ABCB1 p.Met68Cys details
ABCB1 p.Leu65Cys
X
ABCB1 p.Leu65Cys 12223492:130:67
status:
NEW
view ABCB1 p.Leu65Cys details
The activity of
M68C
, was inhibited by 44%, whereas that of mutant
L65C
was increased (189%).
Login to comment
131
ABCB1 p.Tyr118Cys
X
ABCB1 p.Tyr118Cys 12223492:131:14
status:
NEW
view ABCB1 p.Tyr118Cys details
ABCB1 p.Val125Cys
X
ABCB1 p.Val125Cys 12223492:131:21
status:
NEW
view ABCB1 p.Val125Cys details
Four mutants (
Y118C
,
V125C
, V133C, and C137) in TM2 were very sensitive to MTS-rhodamine because they were inhibited 94, 68, 80, and 93%, respectively.
Login to comment
132
ABCB1 p.Gln132Cys
X
ABCB1 p.Gln132Cys 12223492:132:7
status:
NEW
view ABCB1 p.Gln132Cys details
Mutant
Q132C
showed weaker inhibition (32%).
Login to comment
133
ABCB1 p.Gln195Cys
X
ABCB1 p.Gln195Cys 12223492:133:49
status:
NEW
view ABCB1 p.Gln195Cys details
ABCB1 p.Lys189Cys
X
ABCB1 p.Lys189Cys 12223492:133:39
status:
NEW
view ABCB1 p.Lys189Cys details
In TM3, the activities of two mutants (
K189C
and
Q195C
) were inhibited 76 and 78%, respectively, by MTS-rhodamine.
Login to comment
138
ABCB1 p.Asn296Cys
X
ABCB1 p.Asn296Cys 12223492:138:27
status:
NEW
view ABCB1 p.Asn296Cys details
ABCB1 p.Phe314Cys
X
ABCB1 p.Phe314Cys 12223492:138:52
status:
NEW
view ABCB1 p.Phe314Cys details
In contrast, four mutants (
N296C
, G300C, Y310C, and
F314C
) were inhibited by Ͼ70% with MTS-rhodamine.
Login to comment
139
ABCB1 p.Ile340Cys
X
ABCB1 p.Ile340Cys 12223492:139:31
status:
NEW
view ABCB1 p.Ile340Cys details
ABCB1 p.Ala342Cys
X
ABCB1 p.Ala342Cys 12223492:139:41
status:
NEW
view ABCB1 p.Ala342Cys details
The activities of two mutants (
I340C
and
A342C
) in TM6 were strongly inhibited (87 and 94%, respectively) by MTS-rhodamine.
Login to comment
140
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 12223492:140:23
status:
NEW
view ABCB1 p.Phe343Cys details
The activity of mutant
F343C
, however, was increased (347%) after treatment with MTS-rhodamine.
Login to comment
155
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 12223492:155:68
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Ile340Cys
X
ABCB1 p.Ile340Cys 12223492:155:54
status:
NEW
view ABCB1 p.Ile340Cys details
ABCB1 p.Ala841Cys
X
ABCB1 p.Ala841Cys 12223492:155:61
status:
NEW
view ABCB1 p.Ala841Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 12223492:155:79
status:
NEW
view ABCB1 p.Val982Cys details
Lower levels of protection were observed with mutants
I340C
,
A841C
,
L975C
, and
V982C
(Fig. 5).
Login to comment
164
ABCB1 p.Leu65Cys
X
ABCB1 p.Leu65Cys 12223492:164:13
status:
NEW
view ABCB1 p.Leu65Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 12223492:164:22
status:
NEW
view ABCB1 p.Phe343Cys details
Two mutants,
L65C
and
F343C
, showed increased activity after treatment with MTS-rhodamine.
Login to comment
165
ABCB1 p.Leu65Cys
X
ABCB1 p.Leu65Cys 12223492:165:15
status:
NEW
view ABCB1 p.Leu65Cys details
Because mutant
L65C
had only 51% of the verapamil-stimulated ATPase activity relative to that of the Cys-less parent (22), treatment with MTS treatment essentially restored the activity of the mutant to that of the Cys-less P-gp.
Login to comment
167
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 12223492:167:7
status:
NEW
view ABCB1 p.Phe343Cys details
Mutant
F343C
showed about 3.5-fold increase in activity after treatment with MTS-rhodamine.
Login to comment
168
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 12223492:168:15
status:
NEW
view ABCB1 p.Phe343Cys details
Because mutant
F343C
had about 60% of the activity of Cys-less P-gp, reaction with MTS-rhodamine essentially causes a 2-fold increase in activity relative to the Cys-less parent.
Login to comment
172
ABCB1 p.Val52Cys
X
ABCB1 p.Val52Cys 12223492:172:24
status:
NEW
view ABCB1 p.Val52Cys details
ABCB1 p.Gly62Cys
X
ABCB1 p.Gly62Cys 12223492:172:40
status:
NEW
view ABCB1 p.Gly62Cys details
Three cysteine mutants (
V52C
, G54C, and
G62C
) in TM1 were not tested because of low expression, indicating that these residues must be important for structure and/or function.
Login to comment
186
ABCB1 p.Asn839Ile
X
ABCB1 p.Asn839Ile 12223492:186:28
status:
NEW
view ABCB1 p.Asn839Ile details
Mutations in TM9 (I837L and
N839I
) or in TM6 (G388A and A339P) resulted in similar drug resistance profiles with four structurally different drugs (increased resistance to vincristine or actinomycin D but decreased resistance to colchicine or daunorubicin relative to wild-type P-gp).
Login to comment